Azel 40MG Tablet (28’s) is a prescription medication that contains Enzalutamide as its active ingredient, with each tablet delivering a potent dose of 40mg. This drug is primarily indicated for the treatment of metastatic castration-resistant prostate cancer, a condition where prostate cancer continues to progress despite hormone therapy aimed at lowering testosterone levels. Enzalutamide works by inhibiting the androgen receptor signaling pathway, which is crucial for the growth and survival of prostate cancer cells. The formulation of Azel 40MG Tablet is designed to provide effective management of this aggressive cancer type, helping to prolong survival and improve the quality of life for patients. As a targeted therapy, it represents a significant advancement in oncology, offering a more focused approach to combatting prostate cancer while minimizing damage to surrounding healthy tissues.